연구성과로 돌아가기
2024 연구성과별 연구자 정보 (1630 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC | Kim, Jehun | Kim, J | 16 | Kosin Univ, Coll Med, Dept Internal Med, Busan, South Korea | ejspulm@pusan.ac.kr;fireajh@gmail.com; | |||||
| PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC | Park, Jin-Han | Park, JH | 17 | Inje Univ, Coll Med, Dept Internal Med, Busan, South Korea | ejspulm@pusan.ac.kr;fireajh@gmail.com; | |||||
| PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC | Kim, Tae Hoon | Kim, TH | 18 | Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Chang Won, South Korea | GXF-5826-2022 | kim, Tae-hoon | ejspulm@pusan.ac.kr;fireajh@gmail.com; | |||
| PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC | Kim, Tae Hoon | Kim, TH | 18 | Gyeongsang Natl Univ, Changwon Hosp, Chang Won, South Korea | GXF-5826-2022 | kim, Tae-hoon | ejspulm@pusan.ac.kr;fireajh@gmail.com; | |||
| PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC | Eom, Jung Seop | Eom, JS | 19 | 교신저자 | Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Internal Med, Sch Med, 179 Gudeok Ro, Busan 49241, South Korea | ejspulm@pusan.ac.kr;fireajh@gmail.com; | ||||
| PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC | Ahn, June Hong | Ahn, JH | 20 | 교신저자 | Yeungnam Univ, Coll Med, Dept Internal Med, Daegu, South Korea | AAB-3093-2019 | Ahn, June | ejspulm@pusan.ac.kr;fireajh@gmail.com; | ||
| PDK4-mediated metabolic reprogramming is a potential therapeutic target for neovascular age-related macular degeneration | Kim, Juhee | Kim, J | 1 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Ophthalmol, Daegu, South Korea | smpark93@gmail.com;DongHo_Park@knu.ac.kr; | |||||
| PDK4-mediated metabolic reprogramming is a potential therapeutic target for neovascular age-related macular degeneration | Kim, Juhee | Kim, J | 1 | Kyungpook Natl Univ, Cell & Matrix Res Inst, Daegu, South Korea | smpark93@gmail.com;DongHo_Park@knu.ac.kr; | |||||
| PDK4-mediated metabolic reprogramming is a potential therapeutic target for neovascular age-related macular degeneration | Jeon, Yujin | Jeon, Y | 2 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Ophthalmol, Daegu, South Korea | smpark93@gmail.com;DongHo_Park@knu.ac.kr; | |||||
| PDK4-mediated metabolic reprogramming is a potential therapeutic target for neovascular age-related macular degeneration | Jeon, Yujin | Jeon, Y | 2 | Kyungpook Natl Univ, Cell & Matrix Res Inst, Daegu, South Korea | smpark93@gmail.com;DongHo_Park@knu.ac.kr; | |||||
| PDK4-mediated metabolic reprogramming is a potential therapeutic target for neovascular age-related macular degeneration | Son, Jinyoung | Son, J | 3 | Kyungpook Natl Univ, Grad Sch, Dept Biomed Sci, Daegu, South Korea | smpark93@gmail.com;DongHo_Park@knu.ac.kr; | |||||
| PDK4-mediated metabolic reprogramming is a potential therapeutic target for neovascular age-related macular degeneration | Son, Jinyoung | Son, J | 3 | BK21 FOUR KNU Convergence Educ Program Biomed Sci, Daegu, South Korea | smpark93@gmail.com;DongHo_Park@knu.ac.kr; | |||||
| PDK4-mediated metabolic reprogramming is a potential therapeutic target for neovascular age-related macular degeneration | Pagire, Haushabhau S. | Pagire, HS | 4 | Gwangju Inst Sci & Technol, Dept Chem, Gwangju, South Korea | smpark93@gmail.com;DongHo_Park@knu.ac.kr; | |||||
| PDK4-mediated metabolic reprogramming is a potential therapeutic target for neovascular age-related macular degeneration | Pagire, Haushabhau S. | Pagire, HS | 4 | JD Biosci Inc, R&D Ctr, Gwangju, South Korea | smpark93@gmail.com;DongHo_Park@knu.ac.kr; | |||||
| PDK4-mediated metabolic reprogramming is a potential therapeutic target for neovascular age-related macular degeneration | Pagire, Suvarna H. | Pagire, SH | 5 | Gwangju Inst Sci & Technol, Dept Chem, Gwangju, South Korea | smpark93@gmail.com;DongHo_Park@knu.ac.kr; |
페이지 이동: